Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
amifostine (ethyol) (1 trial)
cisplatin (platinol) (2 trials)
docetaxel (taxotere) (1 trial)
etoposide (vepesid) (1 trial)
fluorouracil (efudex) (1 trial)
Head and Neck Neoplasms (Phase 2)
Lung Neoplasms (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Nasopharyngeal Neoplasms (Phase 2)
Pancoast Syndrome (Phase 2)
Preleukemia (Phase 2)
Syndrome (Phase 2)
Trials (3 total)
Trial APIs (5 total)